{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:26:05Z","timestamp":1785147965494,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.canlet.2023.216437","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T11:54:48Z","timestamp":1697111688000},"page":"216437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer"],"prefix":"10.1016","volume":"578","author":[{"given":"Samrita","family":"Dogra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-7663","authenticated-orcid":false,"given":"Sugantha Priya","family":"Elayapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamille","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Filatenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney W.","family":"Houchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-5443","authenticated-orcid":false,"given":"William L.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-9171","authenticated-orcid":false,"given":"Bethany N.","family":"Hannafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.canlet.2023.216437_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/IGC.0000000000001023","article-title":"Impact of recurrence of ovarian cancer on quality of life and outlook for the future","volume":"27","author":"Colombo","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2023.216437_bib3","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1530\/ERC-17-0336","article-title":"Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment","volume":"25","author":"van Zyl","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\"Platinum resistant\" ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2023.216437_bib5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1535-7163.MCT-19-0776","article-title":"DCLK1-Isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization","volume":"19","author":"Chandrakesan","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s42003-021-02631-y","article-title":"Structural basis for small molecule targeting of Doublecortin like Kinase 1 with DCLK1-IN-1","volume":"4","author":"Patel","year":"2021","journal-title":"Commun. Biol."},{"issue":"19","key":"10.1016\/j.canlet.2023.216437_bib7","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.18632\/oncotarget.2393","article-title":"DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition","volume":"5","author":"Chandrakesan","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2023.216437_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1440-1746.2011.06928.x","article-title":"Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma","volume":"27","author":"Vega","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/CBM-210330","article-title":"Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer","volume":"33","author":"Kalantari","year":"2022","journal-title":"Cancer Biomarkers"},{"issue":"22","key":"10.1016\/j.canlet.2023.216437_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225729","article-title":"Inhibition of DCLK1 with DCLK1-IN-1 suppresses renal cell carcinoma invasion and stemness and promotes cytotoxic T-cell-mediated anti-tumor immunity","volume":"13","author":"Ding","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2023.216437_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yexmp.2019.04.015","article-title":"Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas","volume":"108","author":"Shafiei","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.canlet.2023.216437_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2022.01.030","article-title":"Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt\/beta-Catenin activity and cancer stemness","volume":"531","author":"Yan","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng.2481","article-title":"Dclk1 distinguishes between tumor and normal stem cells in the intestine","volume":"45","author":"Nakanishi","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.gastro.2013.09.050","article-title":"DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer","volume":"146","author":"Bailey","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12876-020-01272-5","article-title":"LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b\/DCLK1\/Notch1 axis","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.canlet.2023.216437_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jcmgh.2022.10.013","article-title":"DCLK1 suppresses tumor-specific cytotoxic T lymphocyte function through recruitment of MDSCs via the CXCL1-CXCR2 Axis","volume":"15","author":"Yan","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151089","article-title":"Cisplatin resistant spheroids model clinically relevant survival mechanisms in ovarian tumors","volume":"11","author":"Chowanadisai","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","author":"Gyorffy","year":"2023","journal-title":"Geroscience"},{"issue":"10","key":"10.1016\/j.canlet.2023.216437_bib19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chembiol.2020.07.011","article-title":"Chemical biology toolkit for DCLK1 reveals connection to RNA processing","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"8","key":"10.1016\/j.canlet.2023.216437_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.canlet.2023.216437_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216437_bib22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2023.216437_bib23","first-page":"850","article-title":"Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines","volume":"57","author":"Johnson","year":"1997","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2023.216437_bib24","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"Lanczky","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"2","key":"10.1016\/j.canlet.2023.216437_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/js.2018-00272","article-title":"Follicle-stimulating hormone is an autocrine regulator of the ovarian cancer metastatic niche through notch signaling","volume":"3","author":"Gera","year":"2019","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.canlet.2023.216437_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/2472555217697434","article-title":"3D models of the NCI60 cell lines for screening oncology compounds","volume":"22","author":"Selby","year":"2017","journal-title":"SLAS Discov"},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1039\/C9NR09572A","article-title":"An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics","volume":"12","author":"Singh","year":"2020","journal-title":"Nanoscale"},{"issue":"9","key":"10.1016\/j.canlet.2023.216437_bib28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/1541-7786.MCR-18-1205","article-title":"CD44 regulates formation of spheroids and controls organ-specific metastatic colonization in epithelial ovarian carcinoma","volume":"17","author":"Sacks Suarez","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97434-w","article-title":"Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models","volume":"11","author":"Brodeur","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2023.216437_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41589-020-0506-0","article-title":"Discovery of a selective inhibitor of doublecortin like kinase 1","volume":"16","author":"Ferguson","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.canlet.2023.216437_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.str.2016.07.008","article-title":"Biochemical and structural insights into doublecortin-like kinase domain 1","volume":"24","author":"Patel","year":"2016","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.canlet.2023.216437_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020428","article-title":"Epithelial to mesenchymal transition: a mechanism that fuels cancer radio\/chemoresistance","volume":"9","author":"Dudas","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2023.216437_bib33","series-title":"Ovarian Cancer","article-title":"Recurrent high grade serous ovarian cancer management","author":"Luyckx","year":"2022"},{"key":"10.1016\/j.canlet.2023.216437_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drup.2015.11.005","article-title":"Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: different models for different questions","volume":"24","author":"Alkema","year":"2016","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.canlet.2023.216437_bib35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1172\/JCI73434","article-title":"Long-lived intestinal tuft cells serve as colon cancer-initiating cells","volume":"124","author":"Westphalen","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.canlet.2023.216437_bib36","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1158\/1541-7786.MCR-21-0161","article-title":"DCLK1-Short splice variant promotes esophageal squamous cell carcinoma progression via the MAPK\/ERK\/MMP2 pathway","volume":"19","author":"Ge","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2023.216437_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-017-0594-y","article-title":"Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells","volume":"16","author":"Chandrakesan","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2023.216437_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.omto.2020.05.012","article-title":"DCLK1 regulates tumor stemness and cisplatin resistance in non-small cell lung cancer via ABCD-member-4","volume":"18","author":"Panneerselvam","year":"2020","journal-title":"Mol Ther Oncolytics"},{"issue":"4","key":"10.1016\/j.canlet.2023.216437_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.stem.2016.03.016","article-title":"Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis","volume":"18","author":"Westphalen","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2023.216437_bib40","article-title":"Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: clinical Implications","volume":"5","author":"O'Connell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216437_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biocel.2017.01.020","article-title":"MicroRNA-424 inhibits cell migration, invasion, and epithelial mesenchymal transition by downregulating doublecortin-like kinase 1 in ovarian clear cell carcinoma","volume":"85","author":"Wu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2023.216437_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00424-020-02415-z","article-title":"DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting beta-catenin\/c-Myc signaling","volume":"472","author":"Zhang","year":"2020","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"10","key":"10.1016\/j.canlet.2023.216437_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101406","article-title":"Cisplatin mouse models: treatment, toxicity and translatability","volume":"9","author":"Perse","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2023.216437_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updates"},{"issue":"7","key":"10.1016\/j.canlet.2023.216437_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41419-023-05960-4","article-title":"Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2\/TAK1 signaling pathway","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.canlet.2023.216437_bib46","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","article-title":"Cancer drug resistance induced by EMT: novel therapeutic strategies","volume":"95","author":"De Las Rivas","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.canlet.2023.216437_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.canlet.2023.216437_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","article-title":"The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells","volume":"147","author":"Cordenonsi","year":"2011","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.canlet.2025.217889","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:12:54Z","timestamp":1759594374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523003889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":48,"alternative-id":["S0304383523003889"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216437","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216437"}}